Get the Stockscreener App
8.60
10.51%
-1.01
After Hours:
8.57
-0.03
-0.35%
Tevogen Bio Holdings Inc stock is traded at $8.60, with a volume of 19,043.
It is down -10.51% in the last 24 hours and up +13.91% over the past month.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders. The first clinical product of ExacTcell, TVGN 489, is initially being developed to fill a critical gap in COVID-19 therapeutics for the immunocompromised and the high-risk elderly, with potential applications in both treatment and prevention of chronic, lingering symptoms of the disease (Long COVID). Viruses, including COVID-19, hijack cellular machinery to transform infected cells into virus production plants.
See More
Previous Close:
$9.61
Open:
$9.94
24h Volume:
19,043
Relative Volume:
0.58
Market Cap:
$36.01M
Revenue:
-
Net Income/Loss:
$-26.28M
P/E Ratio:
-2.0051
EPS:
-4.2891
Net Cash Flow:
$-12.39M
1W Performance:
-12.87%
1M Performance:
+13.91%
6M Performance:
-64.24%
1Y Performance:
-86.87%
1-Day Range:
$8.33
$9.94
1-Week Range:
$8.33
$12.00
52-Week Range:
$4.1353
$75.50
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
Name
Tevogen Bio Holdings Inc
Sector
Industry
Phone
646-807-8832
Address
15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN
Compare TVGN vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TVGN
Tevogen Bio Holdings Inc
|
8.60 | 40.24M | 0 | -26.28M | -12.39M | -4.2891 |
VRTX
Vertex Pharmaceuticals Inc
|
435.93 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
634.62 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
808.43 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.50 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.89 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-26 | Downgrade | D. Boral Capital | Buy → Hold |
| Mar-04-25 | Initiated | D. Boral Capital | Buy |
Tevogen Bio Holdings Inc Stock (TVGN) Latest News
Tevogen Bio Holdings Q4 2025 Earnings: Narrower-than-Expected Loss Fails to Lift SharesInstitutional Grade Picks - Newser
Tevogen Bio Holdings Warrant (TVGNW) Stalls at $0.04 as Trading Remains FlatMACD Signal Stocks - Newser
TVGN News | TEVOGEN BIO HOLDINGS INC (NASDAQ:TVGN) - ChartMill
Tevogen Bio Holdings Inc. (TVGN) Stock: Jumps 11.74% on Potential Healthcare Expansion Deal - parameter.io
Tevogen Also Considering Other Transactions With a Focus on Life Sciences and Healthcare-Related Businesses - Moomoo
Tevogen Bio Holdings Inc. Signs Non-Binding Letter of Intent to Explore Strategic Healthcare Transaction - Quiver Quantitative
Tevogen explores MSO deal that could pave path to $100M - Stock Titan
Tevogen Bio Holdings Company Profile & Introduction - Moomoo
TVGN Shares Updates on Operational Improvements and Strategic Go - GuruFocus
Tevogen reports reduced operating losses in 2025 and Q1 2026 By Investing.com - Investing.com Nigeria
Tevogen reports reduced operating losses in 2025 and Q1 2026 - Investing.com
Tevogen ‘working towards’ aligning long-term incentives, performance milestones - TipRanks
Letter to Shareholders from CEO Dr. Ryan Saadi - The Manila Times
Tevogen Bio Holdings Inc. Reports Significant Operational Improvements and Strategic Growth Initiatives - Quiver Quantitative
TVGN Technical Analysis | Trend, Signals & Chart Patterns | TEVOGEN BIO HOLDINGS INC (NASDAQ:TVGN) - ChartMill
Tevogen Bio Holdings Inc. 1Q 2026: Revenue $0 Net loss $(5.45)M — 10-Q Summary - TradingView
Tevogen Bio (TVGN) Q1 loss narrows but cash, Nasdaq listing pressures grow - Stock Titan
Tevogen Bio Holdings Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Number of shareholders of Tevogen Bio Holdings Inc. – NASDAQ:TVGN - TradingView
Tevogen (TVGN) Stock: Secures Fresh Capital to Advance Precision Healthcare Platform - parameter.io
Tevogen announces $3 million private investment at $8 per share, a 14% premium from latest market close - marketscreener.com
Tevogen Bio Holdings Inc. Secures $3 Million PIPE Financing from The Patel Family, LLP - Quiver Quantitative
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest ... - Caledonian Record
Existing backer pays 14% premium in Tevogen’s new $3M cash raise - Stock Titan
TradingKey - TradingKey
symbol__ Stock Quote Price and Forecast - CNN
The growth story Tevogen (TVGNW) is not telling investors (-2.53%) 2026-05-08Blue Chip Stocks - Newser
Tevogen (TVGN) Soars 11% as Firm Gears Up for AI Training Commercialization - Insider Monkey
5 Stocks Exploding in a Bleeding Market - Insider Monkey
Tevogen Bio Holdings Inc. 2025 Annual Report: Executive Compensation, Corporate Governance, Audit Committee, and Key Filings - Minichart
Tevogen Bio (NASDAQ: TVGN) adds governance, pay and related-party details - Stock Titan
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal - markets.businessinsider.com
Tevogen’s drug-targeting AI improves precision, starts commercial prep - Stock Titan
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
TVGN Price Today: Tevogen Bio Holdings Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Tevogen files to sell 30.73M shares of common stock for holders - MSN
Tevogen Bio Faces Nasdaq Market Value Compliance Challenges - The Globe and Mail
Tevogen Bio Holdings Inc. Receives Nasdaq Delisting Notice – Form 8-K Filing April 2026 - Minichart
Tevogen Bio receives Nasdaq notice for non-compliance with listing requirements - Investing.com
Tevogen Bio Holdings Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
Tevogen Bio (NASDAQ: TVGN) warned on Nasdaq $50M, $15M value tests - Stock Titan
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Is Tevogen (TVGN) stock worth watching (Smart Money Active) 2026-04-20Profit Surge - Xã Vĩnh Công
Form 10-KAnnual report [Section 13 and 15(d), not S-K Item 405] - ADVFN
Tevogen Bio Holdings Inc. (TVGNW) - Minichart
Aug Outlook: What is Tevogen Bio Holdings Incs valuation compared to sectorPortfolio Update Summary & Long-Term Growth Stock Strategies - baoquankhu1.vn
Is Tevogen (TVGN) Stock Good for Beginners | Price at $5.74, Up 0.17%Loss Prevention - Xã Thanh Hà
Forecast Cut: Is Tevogen Bio Holdings Inc stock good for income investors2026 PreEarnings & Expert Approved Trade Ideas - baoquankhu1.vn
Tevogen Bio Holdings (TVGN) price target increased by 1,900.00% to 102.00 - MSN
Is Tevogen (TVGN) Stock Expanding | Price at $5.53, Down 5.63%Street Ratings - newser.com
Is Tevogen (TVGNW) Stock showing reversal signs | Price at $0.03, Up 15.19%Market Analysis - Xã Vĩnh Công
Tevogen Bio Holdings Inc Stock (TVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tevogen Bio Holdings Inc Stock (TVGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Flomenberg Neal | See Remarks |
Mar 13 '26 |
Sale |
6.40 |
501 |
3,206 |
76,940 |
| Flomenberg Neal | See Remarks |
Mar 10 '26 |
Sale |
7.75 |
19 |
147 |
77,893 |
0.98%
0.12%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):